Cancer Consortia Members Using Deep Sequencing, Other Strategies to Address Pancreatic Cancer | GenomeWeb

By Andrea Anderson

MONTREAL (GenomeWeb News) – Research teams participating in The Cancer Genome Atlas and the International Cancer Genome Consortium are doing deep exome sequencing — and testing various enrichment strategies — to deal with some of the challenges associated with characterizing pancreatic cancer, attendees of the International Congress of Human Genetics heard at a session on cancer genomes here today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.